Business Context and Reporting Period
Company: New Era Helium Inc. (formerly Roth CH V Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: December 6, 2024
Context: Following the closing of a business combination, the Company entered into a comprehensive financing package with institutional investors to secure capital for working capital and debt repayment. The Company is an emerging growth company listed on The Nasdaq Stock Market LLC under the symbols NEHC (Common Stock) and NEHCW (Warrants).
Key Financial Metrics and Obligations
This filing details the creation of direct financial obligations rather than reporting historical operating results. Key metrics include:
- Equity Purchase Facility (EPFA) Commitment: Up to $75 million in aggregate commitment for the purchase of newly issued common stock (Advance Shares).
- Initial Debt Financing: Two pre-paid advances totaling $10 million in principal, evidenced by senior secured convertible promissory notes.
- First Pre-Paid Advance Note: $7.0 million principal (approx. $6.5 million advanced net of discount).
- Second Pre-Paid Advance Note: $3.0 million principal (to be advanced within 3 trading days of registration statement effectiveness).
- Warrant Financing: Warrants issued to purchase up to $30 million worth of common stock (1,100,000 shares in First Tranche; 2,140,000 shares in Second Tranche).
- Interest Rates: Notes accrue interest at an initial annual rate of 10%, increasing to 18% upon an Event of Default.
- Liquidity Covenant: The Company must maintain a minimum cash balance of $500,000 until the EPFA is terminated.
- Collateral: Notes are secured by a security interest in substantially all assets of the Company and its subsidiaries.
Material Changes and Agreements
The filing reports the execution of several material definitive agreements on December 6, 2024:
- Equity Purchase Facility Agreement (EPFA): Grants the Company the right to sell up to $75 million of shares to an investor at 95% of the market price (subject to adjustments). There is no mandatory minimum usage or non-usage fee.
- Convertible Notes: The Company issued a $7 million note immediately, with a second $3 million note pending. Proceeds are designated for debt repayment and working capital.
- Warrant Purchase Agreement: Issuance of warrants with an initial exercise price of $10.00 per share, subject to anti-dilution adjustments and a floor price of $2.00 (resettable to 20% of VWAP).
- Security and Guarantee Agreements: Execution of a Security Agreement granting a lien on all Company assets and a Subsidiary Guarantee ensuring full payment of obligations.
- Stockholder Approval Requirement: A special meeting of stockholders must be held within 90 days to approve the issuance of shares under these agreements and to increase authorized capital stock to 250,000,000 shares.
Outlook, Risks, and Contingencies
Management Commentary and Use of Proceeds: Proceeds from the initial note are to be used first to repay certain debt, with the remainder for working capital. Future proceeds from the EPFA and second note will prioritize monthly note payments before working capital.
Risks and Contingencies:
- Dilution: Significant potential dilution exists via the EPFA ($75M), Warrants ($30M), and convertible notes ($10M principal).
- Conversion Price Adjustments: Both Notes and Warrants contain "ratchet" provisions where the conversion/exercise price reduces to the effective price of any future dilutive issuance below the current price ($10.00).
- Default Consequences: An Event of Default triggers an interest rate increase to 18% and allows conversion at 90% of the lowest VWAP over the preceding 10 days.
- Issuance Restrictions: While Notes are outstanding, the Company cannot issue securities below 120% of the $2.00 floor price unless proceeds are used to redeem the Notes.
- Ownership Caps: Investors are limited to beneficial ownership of 4.99% (adjustable to 9.99%) until stockholder approval is obtained.
Investor Verification Checklist
- Verify the effectiveness date of the initial Registration Statement, which triggers the $3 million second advance and the 90-day clock for the stockholder meeting.
- Confirm the current cash balance to ensure compliance with the $500,000 minimum liquidity covenant.
- Review the specific terms of the "certain debt" to be repaid with the initial $6.5 million advance to assess immediate liability reduction.
- Monitor the stock price relative to the $10.00 conversion/exercise price and the $2.00 floor price to evaluate potential dilution triggers.
- Check for the filing of the proxy statement for the required stockholder meeting to approve the increase in authorized shares to 250 million.